{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:03:11Z","timestamp":1757617391605,"version":"3.44.0"},"reference-count":32,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,9,1]]},"DOI":"10.2169\/internalmedicine.4852-24","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T17:13:38Z","timestamp":1740762818000},"page":"2657-2662","source":"Crossref","is-referenced-by-count":0,"title":["Spontaneous Remission in a Patient with Anti-OJ Autoantibodies-positive Anti-synthetase Syndrome Following SARS-CoV-2 Infection and mRNA Vaccination"],"prefix":"10.2169","volume":"64","author":[{"given":"Yasuyuki","family":"Todoroki","sequence":"first","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Japan"},{"name":"Department of Molecular Targeted Therapies (DMTT), School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Nakayamada","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippei","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kubo","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Japan"},{"name":"Department of Molecular Targeted Therapies (DMTT), School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotake","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Satoh","sequence":"additional","affiliation":[{"name":"Department of Human, Information and Life Sciences, University of Occupational and Environmental Health, Japan"},{"name":"Department of Medicine, Kitakyushu Yahata-Higashi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Targoff IN. Humoral immunity in polymyositis\/dermatomyositis. J Invest Dermatol 100: 116S-123S, 1993.","DOI":"10.1111\/1523-1747.ep12356607"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Katzap E, Barilla-LaBarca ML, Marder G. Antisynthetase syndrome. Curr Rheumatol Rep 13: 175-181, 2011.","DOI":"10.1007\/s11926-011-0176-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zanframundo G, Faghihi-Kashani S, Scire CA, et al. Defining anti-synthetase syndrome: a systematic literature review. Clin Exp Rheumatol 40: 309-319, 2022.","DOI":"10.55563\/clinexprheumatol\/8xj0b9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 52: 1-19, 2017.","DOI":"10.1007\/s12016-015-8510-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sato S, Kuwana M, Hirakata M. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies. Rheumatology (Oxford) 46: 842-845, 2007.","DOI":"10.1093\/rheumatology\/kel435"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Vulsteke JB, Satoh M, Malyavantham K, Bossuyt X, De Langhe E, Mahler M. Anti-OJ autoantibodies: Rare or underdetected? Autoimmun Rev 18: 658-664, 2019.","DOI":"10.1016\/j.autrev.2019.05.002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Galindo-Feria AS, Notarnicola A, Lundberg IE, Horuluoglu B. Aminoacyl-tRNA synthetases: on anti-synthetase syndrome and beyond. Front Immunol 13: 866087, 2022.","DOI":"10.3389\/fimmu.2022.866087"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tada T, Murao H, Shiratani R, et al. Spontaneous resolution of inflammatory myopathy involving the masseter muscle following COVID-19 mRNA vaccination. Mod Rheumatol Case Rep 8: 77-82, 2023.","DOI":"10.1093\/mrcr\/rxad022"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shimizu H, Matsumoto H, Sasajima T, et al. New-onset dermatomyositis following COVID-19: a case report. Front Immunol 13: 1002329, 2022.","DOI":"10.3389\/fimmu.2022.1002329"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Holzer MT, Krusche M, Ruffer N, et al. New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review. Rheumatol Int 42: 2267-2276, 2022.","DOI":"10.1007\/s00296-022-05176-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Irie Y, Wakabayashi H, Matuzawa Y, Hiruta N, Kaneko K. A case of anti-synthetase syndrome with anti-glycyl tRNA synthetases antibody developed after COVID-19. Cureus 16: e58004, 2024.","DOI":"10.7759\/cureus.58004"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lundberg IE, Tjarnlund A, Bottai M, et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76: 1955-1964, 2017.","DOI":"10.1136\/annrheumdis-2017-212786"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Solomon J, Swigris JJ, Brown KK. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol 37: 100-109, 2011.","DOI":"10.1590\/S1806-37132011000100015"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Labirua-Iturburu A, Selva-O'Callaghan A, Zock JP, Orriols R, Martinez-Gomez X, Vilardell-Tarres M. Occupational exposure in patients with the antisynthetase syndrome. Clin Rheumatol 33: 221-225, 2014.","DOI":"10.1007\/s10067-013-2467-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Shibata M, Makioka K, Hamaguchi Y, Ikeda Y. Favourable complete remission of anti-OJ antibody-positive myositis after lung cancer resection. Rheumatology (Oxford) 61: e77-e79, 2022.","DOI":"10.1093\/rheumatology\/keab808"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Howard OM, Dong HF, Yang D, et al. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 196: 781-791, 2002.","DOI":"10.1084\/jem.20020186"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Katsumata Y, Ridgway WM, Oriss T, et al. Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation. J Autoimmun 29 (2-3): 174-186, 2007.","DOI":"10.1016\/j.jaut.2007.07.005"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Soejima M, Kang EH, Gu X, Katsumata Y, Clemens PR, Ascherman DP. Role of innate immunity in a murine model of histidyl-transfer RNA synthetase (Jo-1)-mediated myositis. Arthritis Rheum 63: 479-487, 2011.","DOI":"10.1002\/art.30113"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fernandez I, Harlow L, Zang Y, et al. Functional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase-induced myositis. J Immunol 191: 1865-1872, 2013.","DOI":"10.4049\/jimmunol.1203070"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sung Y, Yoon I, Han JM, Kim S. Functional and pathologic association of aminoacyl-tRNA synthetases with cancer. Exp Mol Med 54: 553-566, 2022.","DOI":"10.1038\/s12276-022-00765-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Oda K, Kawaguchi T, Satoh M, Yatera K. Spontaneous improvement of interstitial pneumonia with autoimmune features. Intern Med 56: 1607-1608, 2017.","DOI":"10.2169\/internalmedicine.56.8082"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sia R, Massouridis B, Kee NN, Yong B, McLean C, Campbell S. Anti-OJ antibody-positive anti-synthetase syndrome following SARS-CoV-2 infection: a case report and literature review. BMC Rheumatol 8: 37, 2024.","DOI":"10.1186\/s41927-024-00406-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Bouchard Marmen M, Ellezam B, Fritzler MJ, et al. Anti-synthetase syndrome occurring after SARS-CoV-2 infection. Scand J Rheumatol 51: 255-257, 2022.","DOI":"10.1080\/03009742.2021.2024019"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Pena C, Kalara N, Velagapudi P. A case of antisynthetase syndrome in the setting of SARS-Cov-2 infection. Cureus 15: e40588, 2023.","DOI":"10.7759\/cureus.40588"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Elsayed M, Abdelgabar A, Karmani J, Majid M. A Case of antisynthetase syndrome initially presented with interstitial lung disease mimicking COVID-19. J Med Cases 14: 25-30, 2023.","DOI":"10.14740\/jmc4031"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tranah E, MacBrayne A, Bhadauria N, Mukerjee D. A case of antisynthetase syndrome presenting solely with life-threatening interstitial lung disease. Clin Med (Lond) 23: 85-87, 2023.","DOI":"10.7861\/clinmed.2022-0444"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Blake T, Noureldin B. Anti-PL-7 antisynthetase syndrome presenting as COVID-19. Rheumatology (Oxford) 60: e252-e254, 2021.","DOI":"10.1093\/rheumatology\/keab129"},{"key":"28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.5114\/reum.2021.111836","volume":"59","author":"K Gupta","year":"2021","unstructured":"28. Gupta K, Sharma GS, Kumar A. COVID-19 vaccination-associated anti-Jo-1 syndrome. Reumatologia 59: 420-422, 2021.","journal-title":"Reumatologia\/Rheumatology","ISSN":"https:\/\/id.crossref.org\/issn\/0034-6233","issn-type":"print"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Garcia-Bravo L, Calle-Rubio M, Fernandez-Arquero M, et al. Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies. J Transl Autoimmun 5: 100160, 2022.","DOI":"10.1016\/j.jtauto.2022.100160"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Saud A, Naveen R, Aggarwal R, Gupta L. COVID-19 and myositis: what we know so far. Curr Rheumatol Rep 23: 63, 2021.","DOI":"10.1007\/s11926-021-01023-9"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Okiyama N, Yamaguchi Y, Kodera M, et al. Distinct histopathologic patterns of finger eruptions in dermatomyositis based on myositis-specific autoantibody profiles. JAMA Dermatol 2019.","DOI":"10.1001\/jamadermatol.2019.1668"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675, 2012.","DOI":"10.1038\/nmeth.2089"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/17\/64_4852-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:24:54Z","timestamp":1757129094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/17\/64_4852-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":32,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4852-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"4852-24"}}